This inventor holds 5 USPTO granted patents. Top assignees: Recordati S.a. Chemical and Pharmaceutical Company, Recordati S.a.. Active years: 1984-1989.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Casal Pusterlengo, IT (1985)
- Milan, IT (1984 - 1989)
Company Filing History:

Years Active: 1984-1989
Title: The Innovative Work of Pietro Cazzulani
Introduction
Pietro Cazzulani, an accomplished inventor based in Milan, Italy, has made significant contributions to the field of pharmaceuticals. With a total of five patents to his name, Cazzulani has focused his research on developing therapeutically active compounds aimed at treating various medical conditions.
Latest Patents
Cazzulani's latest innovations include two notable patents:
1. **Therapeutically Active Flavonyl-1,4-Dihydropyridines:** This patent describes novel flavonyl-1,4-dihydropyridines, which have been identified as effective calcium antagonists and smooth muscle relaxants.
2. **Antianaphylactic and Antibronchospastic Piperazinyl Compounds:** This invention involves new piperazine derivatives that function as therapeutically useful antianaphylactic and antibronchospastic agents. These compounds include variations in their chemical structure, enhancing their efficacy.
Career Highlights
Throughout his career, Pietro has held positions at Recordati S.a., a reputable chemical and pharmaceutical company, where he has been instrumental in various research initiatives. His work has helped advance the development of innovative treatments that address pressing health issues.
Collaborations
Cazzulani has collaborated with notable colleagues, including Dante Nardi and Alberto Tajana. Together, they have shared insights and contributed to pioneering research that pushes the boundaries of pharmaceutical innovations.
Conclusion
Pietro Cazzulani stands as a remarkable figure in the world of invention, with his patents exemplifying his commitment to improving healthcare through innovative solutions. His work continues to influence the pharmaceutical industry and holds promise for addressing critical medical challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile